Lacticaseibacillus rhamnosus LRH10

Lacticaseibacillus rhamnosus HN001 (formerly classified as Lactobacillus rhamnosus HN001) has been studied across in vitro, animal, and human randomized controlled trial settings.

Lacticaseibacillus rhamnosus R0011 is a well-studied probiotic strain with a research base spanning food technology, immunology, and gut health.

Lacticaseibacillus rhamnosus LRa05 is an emerging probiotic strain with a growing evidence base spanning animal models and several randomized controlled trials.

Lacticaseibacillus rhamnosus LR appears in a range of in vitro and animal studies spanning oral health, gut barrier function, and metabolic research, areas consistent with the broader L.

Lacticaseibacillus rhamnosus GG (LGG) is one of the most extensively studied probiotic strains globally, though the papers linked to this strain entry focus primarily on encapsulation technology and formulation stability…

Lacticaseibacillus rhamnosus, most widely studied as the GG strain, has an extensive research record, though the evidence base in this index is predominantly in vitro and animal-model work.